Industri

OPPI collaborates with NIPER Hajipur to advance researc...

The collaboration aims to strengthen industry-academia collaboration to drive t...

Akums receives DCGI approval for Colchicine 0.5 mg tablets

First-time-in-India approval strengthens Akums’ presence in the growing cardiov...

India is the hub of our R&D strength, process innovatio...

Jeevan Kasara, Chairman of the Board, STERIS Healthcare, believes India’s next ...

Chhattisgarh CM announces 141-acre Pharma Park in Naya ...

The Pharma Park spread across 141 acres, is being built with plug-and-play faci...

Maquet PowerLED II Surgical Light

The Maquet PowerLED II is a surgical light designed for operating-room applicati...

Beyond the Hospital: Strengthening Compliance Across No...

Maintaining safe, compliant non-acute healthcare environments requires coordinat...

UCI Health, Lifepoint Rehabilitation Open 52-Bed Irvine...

The new UCI Health – Irvine Rehabilitation Hospital will provide intensive inpat...

AstraZeneca to invest $2bn in Summit for ADC combinatio...

Under the transaction, AstraZeneca will acquire around 109,000 preferred shares ...

Tolerance Bio signs $560m worldwide TLB-33 deal with Ta...

The agreement grants Tolerance Bio exclusive commercialisation rights outside Ja...

Don’t Miss a Beat: Every Heartbeat Matters

World Heart Day 2026 | 29 September Our heart beats thousands of times every day...

An Interdisciplinary Perspective on the Future Design o...

Cuningham’s work on the Valleywise Health Medical Center resulted in a new, 233-...

Daiichi Sankyo, MSD withdraw cancer drug application

The companies submitted the application seeking accelerated approval in the US. ...

Mirum and Incyte’s Atebrioz approved for FOP in US

The medication aims to reduce the volume of heterotopic ossification (HO) in the...

India’s pharma industry is entering AI execution phase:...

Shammi Thakur, Research Director, Vyansa Intelligence highlights that the next ...

LIB Therapeutics and Sun Pharma announce manufacturing ...

Lerodalcibep is approved in the EU under the brand name Lyrokaul for the treatm...

Lupin receives tentative approval from US FDA for novel...

Global pharma major, Lupin announced that it has received tentative approval fr...